Safety and preliminary efficacy of pembrolizumab following trans-arterial chemoembolization for hepatocellular carcinoma: the PETAL phase Ib study.
Pinato DJ, D'Alessio A, Fulgenzi CAM, Schlaak AE, Celsa C, Killmer S, Blanco JM, Ward C, Stikas CV, Openshaw MR, Acuti N, Nteliopoulos G, Balcells C, Keun HC, Goldin RD, Ross PJ, Cortellini A, Thomas R, Young AM, Danckert N, Tait P, Marchesi JR, Bengsch B, Sharma R.
Pinato DJ, et al. Among authors: tait p.
Clin Cancer Res. 2024 Apr 5. doi: 10.1158/1078-0432.CCR-24-0177. Online ahead of print.
Clin Cancer Res. 2024.
PMID: 38578610